NCT04553055

Brief Summary

Evaluating the important role of the community pharmacists in pandemics like covid-19 and to find whether there was a misuse of antibiotics during the pandemic or not and to define the reasons behind this misuse if any present.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
413

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 20, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2020

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 17, 2020

Completed
Last Updated

December 10, 2020

Status Verified

December 1, 2020

Enrollment Period

2 months

First QC Date

September 15, 2020

Last Update Submit

December 8, 2020

Conditions

Covid19

Keywords

coronavirusobservational surveyantibioticsEgypt

Outcome Measures

Primary Outcomes (1)

  • antibiotic misuse

    using a questionnaire and direct interviews to evaluate the important role of community pharmacist in pandemics like covid-19 and to assess antibiotic misuse during the pandemic or not and to define the reasons behind this misuse if any present

    15-20 days

Study Arms (1)

community pharmacists

Other: online questionnaires

Interventions

online questionnairesOTHER

questionnaire (with detailed questions including how/when/which/for how long antibiotics are prescribed)

community pharmacists

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

community pharmacists worked during the pandemic and dealt with covid-19 patients inside their pharmacies are welcomed to participate

You may qualify if:

  • All community pharmacists worked during the pandemic and dealt with covid-19 patients inside their pharmacies are welcomed to participate

You may not qualify if:

  • Clinical and hospital pharmacists- other medical staff- pharmacist assistant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BeniSuefU

Cairo, BeniSuef, 62511, Egypt

Location

MeSH Terms

Conditions

COVID-19Coronavirus Infections

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Hoda M Rabie, PHD

    lecturer

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principle investigator

Study Record Dates

First Submitted

September 15, 2020

First Posted

September 17, 2020

Study Start

July 20, 2020

Primary Completion

September 15, 2020

Study Completion

September 15, 2020

Last Updated

December 10, 2020

Record last verified: 2020-12

Data Sharing

IPD Sharing
Will not share

Locations

EG(1)